All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
onclive.com
Dr. Pegram on the Development of Trastuzumab Biosimilars | OncLive
Mark D. Pegram, MD, Susy Yuan-Huey Hung Professor, co-director, Stanford's Molecular Therapeutics Program, director, Breast Cancer Oncology Program, Stanford Women's Cancer Center, discusses the development of trastuzumab biosimilars.
Apr 29, 2019
Trastuzumab Side Effects
3:23
Herceptin (Trastuzumab) – Uses, Side Effects, Mechanism of Action, Dosage, Interactions, Warnings
YouTube
Learn Medicine Asap
348 views
8 months ago
0:38
Managing side effects in prolonged treatment with trastuzumab deruxtecan
YouTube
VJOncology
327 views
Oct 11, 2024
3:57
Efectos del Trastuzumab y su Impacto Cardiovascular
TikTok
lavidadespuesdelcancer
1.2K views
Aug 25, 2023
Top videos
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars
onclive.com
Oct 27, 2018
Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars | OncLive
onclive.com
1 month ago
1:30
Dr. Hope Rugo on Trastuzumab Biosimilar in HER2-Positive Breast Cancer
YouTube
OncLive
497 views
Aug 23, 2016
Trastuzumab Mechanism of Action
Mechanism of Action: Herceptin (Trastuzumab) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
targetedonc.com
Jun 29, 2013
5:07
Mechanism of Action | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
enhertuhcp.com
May 26, 2020
Pertuzumab & Trastuzumab in HER2 BC: IV vs. SQ Administration, NCCN Guidelines Recommendation, and Patient Selection
vumedi.com
770 views
Aug 11, 2023
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars
Oct 27, 2018
onclive.com
Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars | Onc
…
1 month ago
onclive.com
1:30
Dr. Hope Rugo on Trastuzumab Biosimilar in HER2-Positive Breas
…
497 views
Aug 23, 2016
YouTube
OncLive
Dr. Kolberg on Collecting Real-World Biosimilar Trastuzumab Dat
…
Sep 4, 2019
onclive.com
14:21
Trastuzumab Deruxtecan FDA Approval and Future Directions fo
…
298 views
May 28, 2024
YouTube
GU Oncology Now
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
165.7K views
Apr 30, 2013
YouTube
HMP Education
Dr. Shah on the Trastuzumab Biosimilar in Gastric Cancer | Onc
…
Oct 24, 2019
onclive.com
3:50
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
44.8K views
Oct 21, 2015
YouTube
Oncology Associates
The Adoption and Choice of Biosimilars | OncLive
Mar 16, 2020
onclive.com
Sandoz AG Re-Submits the Biosimilar Drug EG12014 (Trastuz
…
Jun 13, 2024
marketscreener.com
3:45
Trastuzumab-Deruxtecan: A Game-Changer in HER2-Positive Cancer
…
3.6K views
Aug 5, 2024
YouTube
Pharmacology Insights
6:08
First-Line Treatment of HER2-Positive Metastatic Breast Cancer
2.4K views
Oct 24, 2014
YouTube
OncLive
5:01
Martine J Piccart-Gebhart, Jules Bordet Institute, Université Libre d
…
579 views
Dec 7, 2012
YouTube
Oncoletter
The Availability of Multiple Biosimilars for 1 Biologic | OncLive
Mar 16, 2020
onclive.com
3:32
ENHERTU: Breakthrough Hope for HER2 Positive Cancers
50.2K views
Sep 2, 2023
YouTube
Pharma News & Analysis
4:19
ASCO: New Treatment (T-DM1) for HER2-Positive Advanced Breast C
…
4.5K views
Jun 3, 2012
YouTube
MDedge: news and insights for busy physicians
0:56
El fármaco que cambió el tratamiento del cáncer de mama H
…
16.4K views
4 months ago
YouTube
Farmatiks
5:46
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HE
…
3.1K views
Jan 7, 2020
YouTube
ecancer
9:58
Kimberly L. Blackwell: Primary results from EMILIA
1K views
Jun 3, 2012
YouTube
Oncoletter
11:03
Prof. Xavier Pivot, University Hospital of Besançon, France
1.3K views
Oct 1, 2012
YouTube
Oncoletter
8:42
Trastuzumab Deruxtecan in HER2+ Breast Cancer
508 views
Jul 7, 2020
YouTube
Targeted Oncology
3:04
Trastuzumab Deruxtecan for HER2+ Breast Cancer
8.4K views
Mar 27, 2018
YouTube
OncLive
0:34
Herceptin: Mechanism of action
52.5K views
Aug 2, 2007
YouTube
CancerQuest-CJ
Switching to Biosimilars in Rheumatic Diseases
Mar 11, 2025
medscape.com
2:02
KATHERINE Trial: T-DM1 cuts HER2-positve invasive breast can
…
3.2K views
Dec 12, 2018
YouTube
MDedge: news and insights for busy physicians
3:43
Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low
…
3.7K views
Jan 30, 2020
YouTube
OncLive
1:00
Dr. Slamon on the Use of Trastuzumab and Bevacizumab Bi
…
1.1K views
Apr 25, 2018
YouTube
OncLive
6:48
Pertuzumab adds 16 months survival to trastuzumab plus chem
…
947 views
Nov 11, 2014
YouTube
ecancer
12:12
Breast Cancer Treatment - Trastuzumab Biosimilars
403 views
Jan 11, 2021
YouTube
HPR
See more videos
More like this
Feedback